薄层(T1)黑色素瘤局部、区域及远处复发预测列线图的开发与验证
该研究基于荷兰人群队列(n=25,930)和澳大利亚治疗中心队列(n=2,968),开发并外部验证了预测薄层黑色素瘤(T1,≤1.0 mm)局部、区域和远处无复发生存(RFS)的列线图。列线图区分度良好,C统计量高于仅含T分期和哨兵淋巴结状态的模型,校准曲线显示预测与观察复发率匹配良好。
要点
- 薄层黑色素瘤总体预后良好,但部分患者仍出现复发。
- 列线图可较准确识别高危亚组,区分度优于AJCC分期参数模型。
- 在线计算器已提供,便于临床个体化风险评估。
核心结论
- 列线图能准确识别薄层黑色素瘤复发高危亚组,区分度优于仅含T分期和哨兵淋巴结状态的模型。
研究设计与样本
- 荷兰人群队列(n=25,930)为开发集,澳大利亚黑色素瘤治疗中心队列(n=2,968)为验证集;中位随访分别为6.7年和12.0年。
- 采用多变量Cox模型分别构建局部、区域和远处无复发生存(RFS)列线图。
主要发现
- 荷兰队列局部、区域、远处复发分别为209例(0.8%)、503例(1.9%)、203例(0.8%)。
- 澳大利亚队列局部、区域、远处复发分别为23例(0.8%)、61例(2.1%)、75例(2.5%)。
- 开发模型C统计量:局部RFS 0.79(95%CI 0.75-0.82),区域RFS 0.77(95%CI 0.75-0.78),远处RFS 0.80(95%CI 0.77-0.83)。
- 外部验证C统计量:局部RFS 0.80(95%CI 0.69-0.90),区域RFS 0.76(95%CI 0.70-0.82),远处RFS 0.74(95%CI 0.69-0.80)。
关键数值与推荐
- 校准图显示预测复发率与观察复发率匹配良好。
- 与仅含T分期和哨兵淋巴结状态的模型相比,列线图C统计量在开发队列提高9%-12%,验证队列提高11%-15%。
- 列线图将风险评分最低和最高5%分别定义为低危和高危组。
临床怎么用
- 列线图可用于薄层黑色素瘤患者的个体化复发风险评估,辅助识别高危患者。
- 在线计算器(www.melanomarisk.org.au)已提供,便于临床便捷使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although the prognosis of patients with thin primary cutaneous melanomas (T1, ≤ 1.0 mm) is generally excellent, some develop recurrence. We sought to develop and validate a model predicting recurrences in patients with thin melanomas. METHODS: A Dutch population-based cohort (n = 25,930, development set) and a cohort from an Australian melanoma treatment center (n = 2,968, validation set) were analyzed (median follow-up 6.7 and 12.0 years, respectively). Multivariable Cox models were generated for local, regional, and distant recurrence-free survival (RFS). Discrimination was assessed using Harrell's C-statistic for each outcome. Each nomogram performance was evaluated using calibration plots defining low-risk and high-risk groups as the lowest and top 5% of the nomogram risk score, respectively. The nomograms' C-statistics were compared with those of a model including the current American Joint Committee on Cancer staging parameters (T-stage and sentinel node status). RESULTS: Local, regional, and distant recurrences were found in 209 (0.8%), 503 (1.9%), and 203 (0.8%) Dutch patients, respectively, and 23 (0.8%), 61 (2.1%), and 75 (2.5%) Australian patients, respectively. C-statistics of 0.79 (95% CI, 0.75 to 0.82) for local RFS, 0.77 (95% CI, 0.75 to 0.78) for regional RFS, and 0.80 (95% CI, 0.77 to 0.83) for distant RFS were obtained for the development model. External validation showed C-statistics of 0.80 (95% CI, 0.69 to 0.90), 0.76 (95% CI, 0.70 to 0.82), and 0.74 (95% CI, 0.69 to 0.80), respectively. Calibration plots showed a good match between predicted and observed rates. Using the nomogram, the C-statistic was increased by 9%-12% for the development cohort and by 11%-15% for the validation cohort, compared with a model including only T-stage and sentinel node status. CONCLUSION: Most patients with thin melanomas have an excellent prognosis, but some develop recurrence. The presented nomograms can accurately identify a subgroup at high risk. An online calculator is available at www.melanomarisk.org.au.
引用
- El Sharouni MA, Ahmed T, Varey AHR, et al. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. J Clin Oncol. 2021. PMID: 33600211. doi:10.1200/JCO.20.02446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。